Evidence map›Paper›PMID 25852676›Full record

ArticleFrontiers in microbiology2015

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Marco Goeijenbier, Joost C M Meijers, Fatih Anfasa, Jeroen M Roose, Cornelia A M van de Weg, Kamran Bakhtiari, Heikki Henttonen, Antti Vaheri, Albert D M E Osterhaus, Eric C M van Gorp and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Thrombocytopenia in Virus Infections.Journal of clinical medicine · 2021
    Review
  9. Review
  10. Article
  11. Orthohantavirus Pathogenesis and Cell Tropism.Frontiers in cellular and infection microbiology · 2020
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Marco GoeijenbierDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands.
Joost C M MeijersDepartment of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam Amsterdam, Netherlands ; Department of Plasma Proteins, Sanquin Research, Amsterdam Netherlands.
Fatih AnfasaDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands ; Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia Jakarta, Indonesia.
Jeroen M RooseDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands ; Artemis One Health Institute, Utrecht Netherlands.
Cornelia A M van de WegDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands.
Kamran BakhtiariDepartment of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam Amsterdam, Netherlands ; Department of Plasma Proteins, Sanquin Research, Amsterdam Netherlands.
Heikki HenttonenMetla, Finnish Forest Research Institute, Vantaa Finland.
Antti VaheriDepartment of Virology, Haartman Institute, University Of Helsinki Helsinki, Finland.
Albert D M E OsterhausDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands ; Artemis One Health Institute, Utrecht Netherlands.
Eric C M van GorpDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands.
Byron E E MartinaDepartment of Viroscience, Erasmus MC, Rotterdam Netherlands ; Artemis One Health Institute, Utrecht Netherlands.
Erasmus University Rotterdam · NLErasmus MC · NLSanquin · NLUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Puumala virus (PUUV) infection causes over 5000 cases of hemorrhagic fever in Europe annually and can influence the hemostatic balance extensively. Infection might lead to hemorrhage, while a recent study showed an increased risk of myocardial infarction during or shortly after PUUV infection. The mechanism by which this hantavirus influences the coagulation system remains unknown. Therefore we aimed to elucidate mechanisms explaining alterations seen in primary and secondary hemostasis during PUUV infection. By using low passage PUUV isolates to infect primary human umbilical vein endothelial cells (HUVECs) we were able to show alterations in the regulation of primary- and secondary hemostasis and in the release of fibrinolysis regulators. Our main finding was an activation of secondary hemostasis due to increased tissue factor (TF) expression leading to increased thrombin generation in a functional assay. Furthermore, we showed that during infection platelets adhered to HUVEC and subsequently specifically to PUUV virus particles. Infection of HUVEC with PUUV did not result in increased von Willebrand factor while they produced more plasminogen activator inhibitor type-1 (PAI-1) compared to controls. The PAI-1 produced in this model formed complexes with vitronectin. This is the first report that reveals a potential mechanism behind the pro-coagulant changes in PUUV patients, which could be the result of increased thrombin generation due to an increased TF expression on endothelial cells during infection. Furthermore, we provide insight into the contribution of endothelial cell responses regarding hemostasis in PUUV pathogenesis.

Indexed as

endothelial cellshantavirushemorrhagic fever with renal syndromehemostasisHFRSplateletsthrombin generation

Identifiers

PMID25852676
PMCPMC4371750
OpenAlexW2094791038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.